Chapter title |
Neuroprotective Functions Through Inhibition of ER Stress by Taurine or Taurine Combination Treatments in a Rat Stroke Model
|
---|---|
Chapter number | 17 |
Book title |
Taurine 10
|
Published in |
Advances in experimental medicine and biology, January 2017
|
DOI | 10.1007/978-94-024-1079-2_17 |
Pubmed ID | |
Book ISBNs |
978-9-40-241077-8, 978-9-40-241079-2
|
Authors |
Howard Prentice, Payam M. Gharibani, Zhiyuan Ma, Anamaria Alexandrescu, Rafaella Genova, Po-Chih Chen, Jigar Modi, Janet Menzie, Chunliu Pan, Rui Tao, Jang-Yen Wu, Prentice, Howard, Gharibani, Payam M., Ma, Zhiyuan, Alexandrescu, Anamaria, Genova, Rafaella, Chen, Po-Chih, Modi, Jigar, Menzie, Janet, Pan, Chunliu, Tao, Rui, Wu, Jang-Yen |
Abstract |
Taurine, as a free amino acid, is found at high levels in many tissues including brain, heart and skeletal muscle and is known to demonstrate neuroprotective effects in a range of disease conditions including stroke and neurodegenerative disease. Using in vitro culture systems we have demonstrated that taurine can elicit protection against endoplasmic reticulum stress (ER stress) from glutamate excitotoxicity or from excessive reactive oxygen species in PC12 cells or rat neuronal cultures. In our current investigation we hypothesized that taurine treatment after stroke in the rat middle cerebral artery occlusion (MCAO) model would render protection against ER stress processes as reflected in decreased levels of expression of ER stress pathway components. We demonstrated that taurine elicited high level protection and inhibited both ATF-6 and IRE-1 ER stress pathway components. As ischemic stroke has a complex pathology it is likely that certain combination treatment approaches targeting multiple disease mechanisms may have excellent potential for efficacy. We have previously employed the partial NMDA antagonist DETC-MeSO to render protection against in vivo ischemic stroke using a rat cerebral ischemia model. Here we tested administration of subcutaneous administration of 0.56 mg/kg DETC-MeSO or 40 mg/kg of taurine separately or as combined treatment after a 120 min cerebral ischemia in the rat MCAO model. Neither drug alone demonstrated protection at the low doses employed. Remarkably however the combination of low dose DETC-MeSO plus low dose taurine conferred a diminished infarct size and an enhanced Neuroscore (reflecting decreased neurological deficit). Analysis of ER stress markers pPERK, peIF-2-alpha and cleaved ATF-6 all showed decreased expression demonstrating that all 3 ER stress pathways were inhibited concurrent with a synergistic protective effect by the post-stroke administration of this DETC-MeSO-taurine combination treatment. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 17 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 5 | 29% |
Professor | 1 | 6% |
Student > Doctoral Student | 1 | 6% |
Student > Master | 1 | 6% |
Researcher | 1 | 6% |
Other | 0 | 0% |
Unknown | 8 | 47% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 3 | 18% |
Agricultural and Biological Sciences | 2 | 12% |
Neuroscience | 1 | 6% |
Immunology and Microbiology | 1 | 6% |
Unknown | 10 | 59% |